203 related articles for article (PubMed ID: 38069418)
1. Examining the Potential of Vitamin C Supplementation in Tissue-Engineered Equine Superficial Digital Flexor Tendon Constructs.
Mienaltowski MJ; Callahan M; Gonzales NL; Wong A
Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069418
[TBL] [Abstract][Full Text] [Related]
2. Adding exogenous biglycan or decorin improves tendon formation for equine peritenon and tendon proper cells in vitro.
Pechanec MY; Boyd TN; Baar K; Mienaltowski MJ
BMC Musculoskelet Disord; 2020 Sep; 21(1):627. PubMed ID: 32967653
[TBL] [Abstract][Full Text] [Related]
3. Tendon proper- and peritenon-derived progenitor cells have unique tenogenic properties.
Mienaltowski MJ; Adams SM; Birk DE
Stem Cell Res Ther; 2014 Jul; 5(4):86. PubMed ID: 25005797
[TBL] [Abstract][Full Text] [Related]
4. Gene expression markers of tendon fibroblasts in normal and diseased tissue compared to monolayer and three dimensional culture systems.
Taylor SE; Vaughan-Thomas A; Clements DN; Pinchbeck G; Macrory LC; Smith RK; Clegg PD
BMC Musculoskelet Disord; 2009 Feb; 10():27. PubMed ID: 19245707
[TBL] [Abstract][Full Text] [Related]
5. Decoding the transcriptomic expression and genomic methylation patterns in the tendon proper and its peritenon region in the aging horse.
Pechanec MY; Mienaltowski MJ
BMC Res Notes; 2023 Oct; 16(1):267. PubMed ID: 37821884
[TBL] [Abstract][Full Text] [Related]
6. Examining the Effects of In Vitro Co-Culture of Equine Adipose-Derived Mesenchymal Stem Cells With Tendon Proper and Peritenon Cells.
Pechanec MY; Beall JM; Katzman S; Maga EA; Mienaltowski MJ
J Equine Vet Sci; 2023 Jul; 126():104262. PubMed ID: 36841345
[TBL] [Abstract][Full Text] [Related]
7. Focal experimental injury leads to widespread gene expression and histologic changes in equine flexor tendons.
Jacobson E; Dart AJ; Mondori T; Horadogoda N; Jeffcott LB; Little CB; Smith MM
PLoS One; 2015; 10(4):e0122220. PubMed ID: 25837713
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA29a Treatment Improves Early Tendon Injury.
Watts AE; Millar NL; Platt J; Kitson SM; Akbar M; Rech R; Griffin J; Pool R; Hughes T; McInnes IB; Gilchrist DS
Mol Ther; 2017 Oct; 25(10):2415-2426. PubMed ID: 28822690
[TBL] [Abstract][Full Text] [Related]
9. Intrafascicular chondroid-like bodies in the ageing equine superficial digital flexor tendon comprise glycosaminoglycans and type II collagen.
Ali OJ; Ehrle A; Comerford EJ; Canty-Laird EG; Mead A; Clegg PD; Maddox TW
J Orthop Res; 2021 Dec; 39(12):2755-2766. PubMed ID: 33580534
[TBL] [Abstract][Full Text] [Related]
10. Maturational alterations in gap junction expression and associated collagen synthesis in response to tendon function.
Young NJ; Becker DL; Fleck RA; Goodship AE; Patterson-Kane JC
Matrix Biol; 2009 Jul; 28(6):311-23. PubMed ID: 19481603
[TBL] [Abstract][Full Text] [Related]
11. Age-related changes to the molecular and cellular components of equine flexor tendons.
Birch HL; Bailey JV; Bailey AJ; Goodship AE
Equine Vet J; 1999 Sep; 31(5):391-6. PubMed ID: 10505954
[TBL] [Abstract][Full Text] [Related]
12. Age-related changes of tendon fibril micro-morphology and gene expression.
Ribitsch I; Gueltekin S; Keith MF; Minichmair K; Peham C; Jenner F; Egerbacher M
J Anat; 2020 Apr; 236(4):688-700. PubMed ID: 31792963
[TBL] [Abstract][Full Text] [Related]
13. Fibrin gels exhibit improved biological, structural, and mechanical properties compared with collagen gels in cell-based tendon tissue-engineered constructs.
Breidenbach AP; Dyment NA; Lu Y; Rao M; Shearn JT; Rowe DW; Kadler KE; Butler DL
Tissue Eng Part A; 2015 Feb; 21(3-4):438-50. PubMed ID: 25266738
[TBL] [Abstract][Full Text] [Related]
14. Further characterisation of an experimental model of tendinopathy in the horse.
Cadby JA; David F; van de Lest C; Bosch G; van Weeren PR; Snedeker JG; van Schie HT
Equine Vet J; 2013 Sep; 45(5):642-8. PubMed ID: 23448172
[TBL] [Abstract][Full Text] [Related]
15. Strategies of tenogenic differentiation of equine stem cells for tendon repair: current status and challenges.
Shojaee A; Parham A
Stem Cell Res Ther; 2019 Jun; 10(1):181. PubMed ID: 31215490
[TBL] [Abstract][Full Text] [Related]
16. Effects of platelet-derived growth factor-BB on the metabolic function and morphologic features of equine tendon in explant culture.
Haupt JL; Donnelly BP; Nixon AJ
Am J Vet Res; 2006 Sep; 67(9):1595-600. PubMed ID: 16948608
[TBL] [Abstract][Full Text] [Related]
17. Induction of tenogenic differentiation of equine adipose-derived mesenchymal stem cells by platelet-derived growth factor-BB and growth differentiation factor-6.
Javanshir S; Younesi Soltani F; Dowlati G; Parham A; Naderi-Meshkin H
Mol Biol Rep; 2020 Sep; 47(9):6855-6862. PubMed ID: 32875433
[TBL] [Abstract][Full Text] [Related]
18. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies.
Geburek F; Lietzau M; Beineke A; Rohn K; Stadler PM
Stem Cell Res Ther; 2015 Jun; 6(1):126. PubMed ID: 26113022
[TBL] [Abstract][Full Text] [Related]
19. The effect of recombinant equine growth hormone on the biomechanical properties of healing superficial digital flexor tendons in horses.
Dowling BA; Dart AJ; Hodgson DR; Rose RJ; Walsh WR
Vet Surg; 2002; 31(4):320-4. PubMed ID: 12094345
[TBL] [Abstract][Full Text] [Related]
20. Growth Factor-Mediated Tenogenic Induction of Multipotent Mesenchymal Stromal Cells Is Altered by the Microenvironment of Tendon Matrix.
Roth SP; Schubert S; Scheibe P; Groß C; Brehm W; Burk J
Cell Transplant; 2018 Oct; 27(10):1434-1450. PubMed ID: 30251565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
